Personalized hematopoietic stem cell transplantation for inborn errors of immunity
- PMID: 37090739
- PMCID: PMC10113466
- DOI: 10.3389/fimmu.2023.1162605
Personalized hematopoietic stem cell transplantation for inborn errors of immunity
Abstract
Patients with inborn errors of immunity (IEI) have been transplanted for more than 50 years. Many long-term survivors have ongoing medical issues showing the need for further improvements in how hematopoietic stem cell transplantation (HSCT) is performed if patients in the future are to have a normal quality of life. Precise genetic diagnosis enables early treatment before recurrent infection, autoimmunity and organ impairment occur. Newborn screening for severe combined immunodeficiency (SCID) is established in many countries. For newly described disorders the decision to transplant is not straight-forward. Specific biologic therapies are effective for some diseases and can be used as a bridge to HSCT to improve outcome. Developments in reduced toxicity conditioning and methods of T-cell depletion for mismatched donors have made transplant an option for all eligible patients. Further refinements in conditioning plus precise graft composition and additional cellular therapy are emerging as techniques to personalize the approach to HSCT for each patient.
Keywords: SCID-severe combined immunodeficiency; T cell depletion; conditioning; hematopoietic stem cell transplantation; inborn errors of immunity.
Copyright © 2023 Slatter and Lum.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Allogeneic Hematopoietic Stem Cell Transplantation Activity in Inborn Errors of Immunity in Russian Federation.J Clin Immunol. 2023 Aug;43(6):1241-1249. doi: 10.1007/s10875-023-01476-w. Epub 2023 Apr 3. J Clin Immunol. 2023. PMID: 37009957 Free PMC article.
-
Conditioning regimens for inborn errors of immunity: current perspectives and future strategies.Int J Hematol. 2022 Jul;116(1):7-15. doi: 10.1007/s12185-022-03389-7. Epub 2022 Jun 8. Int J Hematol. 2022. PMID: 35675025 Review.
-
CD3+TCRαβ/CD19+-Depleted Mismatched Family or Unrelated Donor Salvage Stem Cell Transplantation for Graft Dysfunction in Inborn Errors of Immunity.Transplant Cell Ther. 2023 Aug;29(8):513.e1-513.e9. doi: 10.1016/j.jtct.2023.05.019. Epub 2023 Jun 4. Transplant Cell Ther. 2023. PMID: 37279857
-
Survival After Hematopoietic Stem Cell Transplantation in Severe Combined Immunodeficiency (SCID): A Worldwide Review of the Prognostic Variables.Clin Rev Allergy Immunol. 2024 Apr;66(2):192-209. doi: 10.1007/s12016-024-08993-5. Epub 2024 Apr 30. Clin Rev Allergy Immunol. 2024. PMID: 38689103 Review.
-
Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.Immunol Res. 2019 Jun;67(2-3):166-175. doi: 10.1007/s12026-019-09081-z. Immunol Res. 2019. PMID: 31222511
Cited by
-
International multidisciplinary consensus on the definition and clinical approach for monogenic inflammatory immune dysregulation disorders.Pediatr Rheumatol Online J. 2025 May 14;23(1):51. doi: 10.1186/s12969-025-01109-z. Pediatr Rheumatol Online J. 2025. PMID: 40369629 Free PMC article.
-
The Latin American Society for Immunodeficiencies Registry.J Clin Immunol. 2024 Oct 22;45(1):28. doi: 10.1007/s10875-024-01822-6. J Clin Immunol. 2024. PMID: 39436497
-
Editorial: Advances in therapeutic strategies of inborn errors of immunity.Front Immunol. 2023 Nov 9;14:1328846. doi: 10.3389/fimmu.2023.1328846. eCollection 2023. Front Immunol. 2023. PMID: 38022641 Free PMC article. No abstract available.
-
Unmasking inborn errors of immunity: identifying the red flags of immune dysregulation.Front Immunol. 2024 Dec 19;15:1497921. doi: 10.3389/fimmu.2024.1497921. eCollection 2024. Front Immunol. 2024. PMID: 39749336 Free PMC article. Review.
-
Neurological Complications in Inborn Errors of Immunity: A Scoping Review of Clinical Spectrum, Pathophysiological Mechanisms, and Therapeutic Strategies.Clin Rev Allergy Immunol. 2025 Jul 18;68(1):67. doi: 10.1007/s12016-025-09078-7. Clin Rev Allergy Immunol. 2025. PMID: 40681725
References
-
- Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A, et al. Human inborn errors of immunity: 2019 update on the classification from the international union of immunological societies expert committee. J Clin Immunol (2020) 40(1):24–64. doi: 10.1007/s10875-019-00737-x - DOI - PMC - PubMed
-
- Day JW, Elfeky R, Nicholson B, Goodman R, Pearce R, Fox TA, et al. Retrospective, landmark analysis of long-term adult morbidity following allogeneic HSCT for inborn errors of immunity in infancy and childhood. J Clin Immunol (2022) 42(6):1230–43. doi: 10.1007/s10875-022-01278-6 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources